{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:46:12Z","timestamp":1782783972211,"version":"3.54.5"},"reference-count":4,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Human papillomavirus (HPV) represents one of the most clinically significant oncogenic viruses affecting human populations worldwide [...]<\/jats:p>","DOI":"10.3390\/ijms27135865","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:55:11Z","timestamp":1782780911000},"page":"5865","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Special Issue \u201cRecent Advances in Molecular Mechanisms of Human Papillomavirus Family (HPV) Induced Oncogenesis\u201d"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5084-862X","authenticated-orcid":false,"given":"Subhasis B.","family":"Biswas","sequence":"first","affiliation":[{"name":"Department of Medical and Molecular Sciences, College of Health Sciences, University of Delaware, Newark, DE 19716, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1158\/1078-0432.CCR-24-1662","article-title":"Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: A Phase II Trial","volume":"31","author":"Eerkens","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e2409570122","DOI":"10.1073\/pnas.2409570122","article-title":"Stimuli-Responsive STING Nanovaccine for Systemic Therapy of HPV-Induced Cancers","volume":"122","author":"Chen","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/GCO.0000000000001079","article-title":"New Developments in the Treatment of Cervical Cancer in 2026","volume":"38","author":"Muzzarelli","year":"2026","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_4","unstructured":"Smith, M.A., Hall, M.T., Saville, M., Brotherton, J.M.L., and Canfell, K. (2026, April 23). Progress Towards Cervical Cancer Elimination in Australia: 2025 Annual Report of the NHMRC Centre of Research Excellence in Cervical Cancer Control. Available online: https:\/\/report.cervicalcancercontrol.org.au\/."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/5865\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:18:36Z","timestamp":1782782316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/5865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":4,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27135865"],"URL":"https:\/\/doi.org\/10.3390\/ijms27135865","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}